You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Perfluorocarbons

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ischemic Stroke Trial in Little Rock (0.05 mL/kg DDFPe, 0.05 mL/kg Placebo, 0.10 mL/kg DDFPe)

Completed
Has Results
  • Ischemic Stroke
  • 0.05 mL/kg DDFPe
  • +5 more
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Aug 30, 2021

Asthma Trial in Calgary (S1226(8%), Placebo)

Completed
  • Asthma
  • Calgary, Alberta, Canada
    Respiratory Clinical Trials Centre, University of Calgary
Feb 15, 2019

Sickle Cell Disease Trial (NVX-508)

Withdrawn
  • Sickle Cell Disease
  • (no location specified)
Jul 12, 2018

Adverse Reaction to Diagnostic Agents and Kits Nos Trial in London (19F Cell Sense-labeled PBMC, MRI)

Not yet recruiting
  • Adverse Reaction to Diagnostic Agents and Kits Nos
  • 19F Cell Sense-labeled PBMC
  • MRI
  • London, Ontario, Canada
    Robarts Research Institute
May 22, 2018

Respiratory Distress Syndrome, Adult, Acute Lung Injury Trial in Beijing (Perfluorocarbon, Sterile Water for Injection)

Unknown status
  • Respiratory Distress Syndrome, Adult
  • Acute Lung Injury
  • Beijing, Beijing, China
  • +1 more
Apr 9, 2012

Inflammatory Bowel Disease Trial in Charlottesville (Definity)

Terminated
  • Inflammatory Bowel Disease
  • Definity
  • Charlottesville, Virginia
    University of Virginia
Apr 25, 2011